undamentalytics Newsletter
Sign in

Adapthealth Corp. income statement

In fiscal 2025, Adapthealth Corp. reported revenue of $3.24bn, down 0.5% on the year before, operating income of $90.9m (a 2.8% margin) and net income of −$70.8m, or −$0.52 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue3455301,0562,4552,9713,2003,2613,2453,227
Cost of revenue2934418992,0092,3902,5762,5802,6362,677
Gross profit5289158446580624681609550
General and administrative185689168325335359382390
Operating income312971226190−59826491−144
Interest expense7394195109130125104—
Income before tax22−22−20619198−724136−15−247
Income tax−21−123325−494151−12
Net income23−21−16215669−67990−71−228
Diluted EPS$0.97−$0.95−$3.08$0.67$0.33−$5.31$0.61−$0.52−$1.69
Diluted shares (average)24m23m52m133m139m134m136m135m135m
EBITDA7992154484542−216629473266

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AHCO vs AMNAHCO vs ASTHAHCO vs CHE

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Adapthealth Corp.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Adapthealth Corp.